Researchers from Lifordi Immunotherapeutics Inc. have developed a novel antibody-drug conjugate (ADC) called LFD-200 that aims to selectively deliver a potent glucocorticoid (GC) payload directly to ...

A medication often prescribed to reduce symptoms among people with lung cancer limits the effectiveness of certain treatments ...

Single-cell analyses revealed molecular profiles that can distinguish PTSD from depression, potentially leading to better ...

A world-first clinical trial led by Uppsala University Hospital has shown that gene-edited donor islet cells can survive and ...

It is already well known that when a mother experiences inflammation during pregnancy, her child is more likely to develop allergic diseases. Recently, a KAIST research team became the first in the ...

Excessive allergic responses in children can originate from inflammation in the placenta during pregnancy , which alters the ...

Sanofi wins EMA's orphan drug status for rilzabrutinib to treat IgG4-RD, a chronic, immune-mediated rare disease.